Soleo Health Launches Specialty Pharmacy for Rare Diseases

New SoleoRare brand unites experienced teams to deliver exceptional care for complex patient needs.

Apr. 20, 2026 at 1:00pm

Got story updates? Submit your updates here. ›

A translucent X-ray photograph revealing the intricate internal structure of a rare disease medication device, conveying the clinical yet delicate nature of rare disease treatments.Soleo Health's new SoleoRare brand aims to provide specialized pharmacy services tailored to the complex needs of rare disease patients.Frisco Today

Soleo Health, a national provider of specialty pharmacy services, announced the launch of SoleoRare, a dedicated rare disease specialty pharmacy. SoleoRare brings together Soleo's experienced rare disease patient care, patient access, and commercial teams under a specialized care model focused on the unique needs of rare, ultra-rare, and orphan disease patients and their caregivers.

Why it matters

Rare disease patients require a higher level of personalized care and support that standard pharmacies often struggle to provide. Soleo's investment in SoleoRare demonstrates the company's commitment to serving this underserved patient population with tailored clinical expertise, patient resources, and commercial infrastructure.

The details

SoleoRare was built to deliver exceptional outcomes for rare disease patients, caregivers, providers, payors, and pharmaceutical partners. The new brand unites Soleo's dedicated rare disease teams focused on clinical care, patient access, and commercial support. This specialized approach aims to improve the patient experience and drive positive clinical and economic results.

  • Soleo Health announced the launch of SoleoRare on April 20, 2026.

The players

Soleo Health

A leading, independent national provider of complex specialty pharmacy services and infusion therapy.

Drew Walk

Chief executive officer of Soleo Health.

Craig Vollmer

Chief commercial officer of Soleo Health.

SoleoRare

Soleo Health's new dedicated Rare Disease Specialty Pharmacy.

Got photos? Submit your photos here. ›

What they’re saying

“Rare disease patients require more than a standard pharmacy experience; they deserve a dedicated care team that truly understands their journey.”

— Drew Walk, Chief executive officer of Soleo Health

“Pharma partners developing rare and orphan therapies require a more specialized distribution channel, they need a true clinical and commercial partner.”

— Craig Vollmer, Chief commercial officer

What’s next

Soleo Health plans to continue investing in and expanding the capabilities of SoleoRare to better serve the unique needs of rare disease patients and their caregivers.

The takeaway

Soleo Health's launch of SoleoRare demonstrates the growing importance of specialized pharmacy services tailored to the complex requirements of rare disease patients. This new brand reflects the company's commitment to providing exceptional, personalized care that can improve outcomes for this underserved population.